Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging.
Our small molecules are aimed at stimulating biological resilience to stress during aging.
Ruvembri - in regulatory and clinical phases - is our leading drug candidate is administered orally:
• for the treatment of severe respiratory events related to COVID-19 following positive results in Phase 2/3 clinical study (COVA)
• for the treatment of reduced mobility in elderly patients with sarcopenia, with promising results in a Phase 2 clinical study (SARA) conducted in the United States and Europe
A pediatric formulation of Ruvembri is being developed with IND granted in the US and Belgium (MYODA) for the treatment of Duchenne Muscular Dystrophy (DMD).
Company Details
- Employees
- 23
- Founded
- -
- Address
- 4, Place Jussieu, Paris,ile De France 75005,france
- Phone
- +33 1 44 27 23 00
- Industry
- Biotechnology
- Website
- biophytis.com
- HQ
- Paris, Ile de France
Biophytis - Live Healthier Longer Questions
Biophytis - Live Healthier Longer's helpline number is +33 1 44 27 23 00
Biophytis - Live Healthier Longer's website is biophytis.com
Biophytis - Live Healthier Longer's LinkedIn profile is https://fr.linkedin.com/company/biophytis
Biophytis - Live Healthier Longer has
23 employees.
View email and phone details for 23
employees at Biophytis - Live Healthier Longer.
Biophytis - Live Healthier Longer's industry is
Biotechnology
Biophytis - Live Healthier Longer's top competitors are
Bioprojet,
Aelis Farma,
Abivax,
Inotrem,
Genfit,
Ose Immunotherapeutics,
Valerio Therapeutics,
Bioprojet Biotech,
Cellectis,
Innate Pharma.
Biophytis - Live Healthier Longer's categories are Biotechnology
Biophytis - Live Healthier Longer's founding year is 2006
